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RESEARCH ARTICLE Open Access
Analysis of RNA expression of normal and
cancer tissues reveals high correlation of
COP9 gene expression with respiratory
chain complex components
Christina A. Wicker and Tadahide Izumi*
Abstract
Background: The COP9 signalosome, composed of eight subunits, is implicated in cancer genetics with its
deneddylase activity to modulate cellular concentration of oncogenic proteins such as IkB and TGFβ. However, its
function in the normal cell physiology remains elusive. Primarily focusing on gene expression data of the normal
tissues of the head and neck, the cancer genome atlas (TCGA) database was used to identify groups of genes that
were expressed synergistically with the COP9 genes, particularly with the COPS5 (CSN5), which possesses the
catalytic activity of COP9.
Results: Expressions of seven of the COP9 genes (COPS2, COPS3, COPS4, COPS5, COPS6, COPS7A, and COPS8) were
found to be highly synergistic in the normal tissues. In contrast, the tumor tissues decreased the coordinated
expression pattern of COP9 genes. Pathway analysis revealed a high coordination of the expression of the COPS5
and the other COP9 genes with mitochondria-related functional pathways, including genes encoding the
respiratory chain complex.
Conclusions: The results indicate that mRNA expression data for the matched normal tissues available in TCGA are
statistically reliable, and are highly useful to assess novel associations of genes with functional pathways in normal
physiology as well as in the cancer tissues. This study revealed the significant correlation between the expressions
of the COP9 genes and those related to the mitochondrial activity.
Background
The constitutive Photomorphogenesis (CSN) 9, or COP9
signalosome, is a critical multi-functional protein complex
in cells [1, 2]. COP9, originally discovered in Arabidopsis
thalania as a negative regulator of photomorphogenesis,
was later found to be highly conserved across many
species [3, 4]. COP9 is a 450–550 kDA holocomplex com-
posed of eight subunits whose official gene symbols are
listed in Table 1 [1, 5]. COP9 has catalytic activity to
remove Nedd8, a small-ubiquitin like modifier, to regulate
cullin-RING ubiquitin E3 ligases, and thus protein degrad-
ation pathways mediated by cullin complexes [1]. COP9
regulates phosphorylation of proteins such as tumor
suppressor p53, and neddylation essential to ubiquitin-
mediated proteolysis of key proteins including tumor sup-
pressor HIF-1α [6–10]. Thus, COP9 has been an import-
ant focus in cancer genetics [5, 10–13].
Despite intense studies in the past, the exact essential
role of COP9 still remains unknown. This is largely due
to COP9’s promiscuous property to interact with a
variety of cullin complexes and others, and to affect
stabilities of a number of cellular factors. Additionally,
subforms of COP9 complexes were reported [2, 14, 15].
Dubiel et al. proposed that such flexible conformation
enables the broad range of substrates.
Among the eight subunits, COPS5 is the most exten-
sively studied subunit that has numerous critical functions
including deneddylation reactions [1, 10]. It is commonly
over-expressed in cancers leading to increased deneddyla-
tion within cells [16]. Other subunits have been shown to
possess unique functions. For example, CSN1 (GPS1) is
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involved in stabilization of p53 [10, 13]. Over-expression
of COPS2 is linked to chromosome instability [10, 13].
Both COPS2 and COPS3 knockout are embryonic lethal
at E3.5 and E8.5 respectively [10, 13]. COPS6 is frequently
over-expressed in cancer [10]. COPS8 knockout is also
embryonic lethal (E7.5) with impaired growth and differ-
entiation [10]. Although these reports convincingly indi-
cate that all the COP9 subunits have essential functions in
mammalian cells, how these reported functions contribute
to COP9 activity remains largely unknown.
Identification of functional groups with which COP9
signalosome may interact in normal physiology may pro-
vide an important clue to understand how dysregulation
of COP9 may facilitate tumorigenesis.
Deficiency in even one subunit leads to COP9
destabilization. Down-regulation of COPS5 in mouse
embryonic fibroblasts drastically decreased the stability
of COPS1, COPS3, and COPS8 [17–19]. Therefore, it is
plausible that coordinated expression of COP9 genes is
needed to maintain necessary amounts of COP9 and
imbalance may be associated with disease [20]. To eluci-
date this possibility, a statistically adequate number of
normal tissues must be analyzed with precision for their
gene expressions. Using cultured cell lines is not appro-
priate for this investigation, because the cell lines estab-
lished in vitro are all transformed and thus expressions
of the COP9 genes are likely altered from cells in normal
in vivo conditions.
The Cancer Genome Atlas (TCGA) has procured speci-
mens from more than 500 human tumor tissues from vari-
ous cancers for comprehensive analyses of tumor tissues
and advanced cancer genomics. Importantly, matched
normal tissues have been analyzed for about 10% of each
cancer type. Using the RNAseq expression data in TCGA,
we elucidated the possibility that expression of the COP9
genes are synchronized in the normal cells. Indeed the
COP9 gene expressions were in synergy in the nor-
mal tissues, but this fine coordination was diminished
in the tumor tissues. Furthermore, the analysis led to
the unexpected observation that the expressions of the
COP9 genes were highly synchronized with those involved
in mitochondrial biogenesis, particularly those of respira-
tory chain complex.
Methods
Nomenclature of COP9 genes
Although the gene names from CSN1 to CSN8 are intui-
tive and have been accepted as the names for the COP9
subunits [21], the TCGA uses the official gene symbols.
For the simplicity, this study used the official gene sym-
bols as the names of COP9 subunits (Table 1).
Data obtained from TCGA
The mRNA expression data of normal and tumor tis-
sues were obtained through TCGA’s online data portal
site (http://cancergenome.nih.gov). The cancer tissues
chosen for this study are 522 cases of head and neck
squamous cell carcinoma with 44 normal tissues, as
well as lung adenocarcinoma (50 normal and 502
tumor). Normalized gene expression results (mRNA
Seq2 level3) were collected. Each set of mRNA expres-
sion data contained 20,531 gene entries, which were
linked to annotations through DAVID functional gene an-
notation database (Database for Annotation, Visualization
and Integrated Discovery; https://david.ncifcrf.gov), yield-
ing 20,154 analyzable gene lists. The RNAseq data were
linked to information about the chromosome cytoband
and gene ontology (GOTERM_BP_FAT, GOTERM_CC_
FAT, GOTERM_MF_FAT, and KEGG_PATHWAY).
Similarly, the de-identified clinical information in-
cluding anatomical sites and smoking history were re-
trieved from TCGA. Data processing and analysis were
carried out using R (ver 3.1.2) and series of command
line programs developed with the Swift language using
Xcode ver. 6.
Generation of correlation coefficient table specific for
individual genes
Gene expression data of normal and tumor tissues from
donors were assembled into a single table file consist-
ing of columns of tissues and rows of genes. Genes that
show zero mRNA values in more than 5% of the tissues
analyzed were excluded unless noted otherwise. Pear-
son’s correlation coefficient (r) values between expres-
sions of a target gene (e.g., COPS5) and each of all the
other genes were determined, and the genes were then
sorted based on the r values. Significance of r values
were assessed with p values calculated with cor.test
function in R. Pair and boxplots were drawn for par-
ticular gene sets using R.
Table 1 Nomenclature of mammalian COP9 genes
COP9 Genes
Protein Gene Symbol Gene ID Cytoband
CSN1 GPS1 2873 17q25.3
CSN2 COPS2 9318 15q21.2
CSN3 COPS3 8533 17p11.2
CSN4 COPS4 51138 4q21.22
CSN5 COPS5 10987 8q13.2
CSN6 COPS6 10980 7q22.1
CSN7A COPS7A 50813 12p13.31
CSN7B COPS7B 64708 2q37.1
CSN8 COPS8 10920 2q37.3
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Expressional correlation of genes closely localized on the
chromosomes
Generation of cytoband plots
Genes ranked within 500 highest |r| values were pooled,
and the cytoband information was processed into float
values by the simple formula as following. For a gene with
cytoband of ApB.N or AqB.N, a float value was generated
by A - (B.N)/100 or A + (B.N)/100, respectively. For ex-
ample, 8p11.2 was converted to 8–11.2/100 = 7.888, and
8q11.2 was to 8.112. Values of (x, y) = (cytoband, r) was
plotted using R. X and Y chromosomes were shown in
one column as all analyzed genes mapped in X chromo-
some were also found in Y chromosome.
Consideration of exact transcription start sites
Transcriptional start sites of the COP9 genes were re-
trieved from the Ensemble database. For a particular
geneA in the RNAseq data, a group of genes (Gi)
localized within 1 Mbp of the geneA were pooled (the
number of genes in Gi = Nh). Then, an enrichment
score (ES) for the Gi was calculated based on the
correlation coefficient table for geneA [22]. Prior to
this calculation, geneA itself (r = 1) was removed from
the table. Separately, genes localized on the same
chromosome but outside of the 1 Mbp of geneA were
pooled (Go) and used to calculate control mean ES
and standard deviation (sd) for the Nh number of
genes that were randomly selected from the Go gene
pool. This calculation was repeated for 1000 times to
obtain mean and sd values which were used to gener-
ate a p value based on pnorm function with R. To
compare these ES values with other genes, the above
calculation was performed with all available genes in
the RNAseq data, and the p-values were used to calcu-
late false discovery rates (FDR; Benjamini–Hochberg)
using p.adjust function in R.
Interpretation of functional gene annotation
The top 1000 genes with the highest |r| values were
pooled with each gene accompanying gene ontology
(GO) and KEGG pathway information. Over-represented
pathways are sorted by the p values based on binomial
distribution: 1 - pbinom(n, 1000, μ) (in R), where n is the
actual count occurring in the 1000 genes, and μ is the
average of finding the particular pathways, and calculated
with the whole gene set of 20,154.
Derivation of enrichment score (ES) for KEGG functional
pathways
ES scores were calculated by the method described
previously [22]. For example, an ES for COPS5 to oxi-
dative phosphorylation pathway was calculated using
the COPS5 correlation coefficient table with gene an-
notations based on the association with “hsa00190”
(KEGG i.d. for oxidative phosphorylation) to generate
Phit - Pmiss. ES was provided as the maximum value of
Phit - Pmiss as described [22]. A histogram of ES values
was calculated with randomly chosen Nh genes for iter-
ation of 1000, and the distribution was used to assess the
statistical significance.
ESs and corresponding p values were calculated for all
genes and then false discovery rates were determined as
described above.
Results
A single gene expression analysis
COPS5 (official gene symbol of CSN5) is responsible for
the deneddylation activity of the COP9 signalosome, and
also known as Jab1 to activate c-Jun (Jun-activating/
binding protein). Thus, most COP9 studies have focused
on the activity of COPS5 [23] and its influence on bio-
logical activities including tumorigenesis. Because of the
pivotal role of COPS5 for the COP9 signalosome in
mammalian cells, this study primarily focused on COPS5
to investigate the possibility of coordinated expression of
the COP9 subunits in the normal and tumor tissues.
Our primary interest was the head and neck squamous
cell carcinoma (HNSCC), where effects of smoking and
influences of major genetic factors, including p53, p16,
AKT1 and K-Ras could be addressed due to its established
cancer etiology involving these genes. In addition, HNSCC
data in TCGA included a few distinct anatomical sites
including oral cavity, tongue and larynx, and thus effects
of tissue sites for the gene expression could be elucidated
with the clarified clinical record. For the simplicity, the
official gene symbols will be used in this study instead of
more commonly used protein names (Table 1).
Expression of the COPS5 gene was examined using
the data of 44 normal head and neck tissues available in
TCGA. COPS5 expression in normal tissues showed
mean value of 1261.0 with standard deviation (sd)
328.83 and coefficient of variation (sd/mean) 0.26. As a
comparison, mean coefficient of variation of the 15,660
gene set was calculated, and found to be 0.693 (±0.575).
Therefore, the COPS5 gene expression appeared to be
relatively stable among normal oral tissues.
Coordinated expression of the COP9 genes in normal
tissues
Expression patterns of COPS5 and other COP9 genes
were elucidated by comparing correlation coefficients
(expressed as r thereafter), using the RNA expression
data (RNAseqV2 level 3). High positive correlations were
found among the COP9 gene expressions. Specifically,
relative to COPS5, all the other COP9 genes except
COPS7B showed statistically significant positive r values
(Table 2 and Fig. 1). GPS1 (CSN1) showed a smaller r
value than the others, namely COPS2, COPS3, COPS4,
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COPS6, COPS7A, and COPS8. The lower correlation of
gene expression of GPS1 vs. COPS5 was found to be a
general characteristic through our analyses in this study.
However, the positive correlation between GPS1 and
COPS5 was still statistically significant (p = 0.011). In
addition to the low r value relative to the other COP9
genes, the level of COPS7B expression was significantly
lower compared to COPS7A (Additional file 1: Figure S1).
These results indicated that the expressions of COP9
genes were synchronized in human normal oral tissues.
Leppert et al. recently observed that mRNA levels of
COP9 genes were regulated by let-7 miRNA [20]. To
probe the importance of the regulatory mechanism by
miRNA, the TCGA miRNA dataset was used to determine
the gene expression correlation of COP9 genes and the
let-7 miRNA species (Additional file 2: Table S1). There
were statistically significant negative correlations be-
tween let-7 isoforms (7a, 7b, 7c, 7e, 7f-2, 7 g) and
COP9 genes (GPS1, COPS5, COPS6, and COPS8),
which was consistent with the previous work.
Loss of synergistic expressions of the COP9 genes in
cancer tissues
To determine whether the synergistic expressions of
the COP9 genes are maintained in the cancer tissues,
42 tumor tissues matched to the normal cases were
pooled (2 normal cases could not be matched based on
the id tag), and determined their correlation coeffi-
cients (Table 3). High positive r values were observed
among COP9 genes in normal tissues as expected. In
contrast, the correlations of expressions among COP9
genes diminished in the matched tumor tissues (Table 3
and Additional file 2: Table S2). Moreover, the negative
effect of let-7 miRNA observed in the normal tissue data-
set was diminished in the matched tumor tissues
(Additional file 2: Table S1). These results demonstrated
that the coordinated expression of COP9 genes was
diminished in these tumor tissues.
Validation of the results with subgroups (age, anatomical
sites, and smoking history)
HNSCC is an age-related disease. The majority of speci-
mens in TCGA are from elderly patients (median = 61;
the first quartile = 53, the third quartile = 69), and less
than 4% of the patients are younger than 40 years old.
Thus, the loss of the coordination of the COP9 gene
expressions may be due to the age-related degeneration
of the coordination. However, we analyzed the COP9
expression in the 31 tumor tissues that were 42 years
old or younger to the 30 tumor tissues that were 80 years
old or older (Additional file 2: Table S3 A and B). With
this analysis, we found similar loss of the coordinated
expressions in specimens from both the young and eld-
erly patients. In addition, there were no significant dif-
ferences of the expression levels of each COP9 gene
between the young and aged groups (Additional file 2:
Table S3C). These results support that the age is not a
factor causing the low coordination of the COP9 genes
in the tumor specimens.
The oral tissues in TCGA were taken from different
anatomical sites (oral cavity, tongue, etc.). The synergis-
tic expression of COP9 subunit genes may vary depend-
ing on the exact site of oral tissues. To assess this
possibility, the data set was arranged into subgroups
based on the sites. The major groups were the oral cavity
(14 specimens) and the oral tongue (13 specimens). The
data sets of the two subgroups were used to determine
correlation coefficients of the COP9 genes. These values
were similar to those of the entire dataset (Additional
file 2: Table S4 and Additional file 2: Table S5), indicat-
ing that the synergistic expression of the COP9 genes
are maintained regardless of the sites of the oral tissues.
Table 2 Correlation of expression of COP9 genes in normal oral tissues
Head and Neck, Normal
GPS1 COPS2 COPS3 COPS4 COPS5 COPS6 COPS7A COPS7B COPS8
GPS1 1.000 −0.033 0.306 0.369 0.381 0.749 0.514 0.269 0.512
COPS2 −0.033 1.000 0.809 0.687 0.697 0.124 0.613 −0.376 0.411
COPS3 0.306 0.809 1.000 0.776 0.838 0.553 0.785 −0.285 0.455
COPS4 0.369 0.687 0.776 1.000 0.794 0.386 0.805 −0.337 0.831
COPS5 0.381 0.697 0.838 0.794 1.000 0.533 0.851 −0.135 0.619
p 0.01 1.51E-07 1.31E-12 1.28E-10 - 1.98E-04 2.57E-13 0.384 7.69E-06
COPS6 0.749 0.124 0.553 0.386 0.533 1.000 0.495 0.191 0.300
COPS7A 0.514 0.613 0.785 0.805 0.851 0.495 1.000 −0.306 0.673
COPS7B 0.269 −0.376 −0.285 −0.337 −0.135 0.191 −0.306 1.000 −0.161
COPS8 0.512 0.411 0.455 0.831 0.619 0.300 0.673 −0.161 1.000
The RNA expression data obtained from TCGA were analyzed for Pearson’s correlation coefficients. The number of specimens = 44. P values for COPS5 vs. other
COP9 genes were calculated as described based on paired samples algorithm in R (cor.test (gene A, gene B, method = “pearson”, alternative = “two.sided”)
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Similarly, there appeared to be no clear effects of smoking,
because analyzing the normal tissues from eleven current
smokers identified a highly similar synergistic RNA expres-
sions of COP9 genes (Additional file 2: Table S6).
Chromosome mapping of genes of high synergy with the
COPS5 expression
To elucidate the tumor-associated disintegration of the
COP9 gene expression in detail, we focused on the COPS5
gene. We generated a “correlation table” of the COPS5, in
which expressional correlation coefficients relative to the
COPS5 gene (rCOPS5) were calculated for all the analyzable
genes (about 14,000 genes). By cross-referring the results
to gene ontology provided with DAVID, we noticed that
genes with high rCOPS5 of the tumor tissues were mapped
in the same chromosomal location as the COPS5 gene
(8q13.2, Table 1). We thus speculated that the loss of the
coordination of the COP9 expressions in the tumor tissues
was not due to unpredictably disorganized expressions of
the COP9 subunit genes, but rather there was a dominant
effect of the physical locations of the genes on their
expressions. To illustrate this possibility, chromosomal
locations of 500 genes with top | rCOPS5| values were plot-
ted on chromosomes based on the cytoband information
(Fig. 2, top). The genes with high |rCOPS5| in the normal
tissues were distributed through all the chromosomes;
Fig. 1 Pair-wise plot of expressions of COP9 genes. The RNA expression results from normal 44 oral tissues are plotted. 1: GPS1, 2: COPS2, 3:
COPS3, 4: COPS4, 5: COPS5, 6: COPS6, 7A: COPS7A, 7B: COPS7B, 8: COPS8
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Table 3 Loss of coordinated COP9 gene expression in HNSCC
Normal vs. Tumor (paired 42)
Normal GPS1 COPS2 COPS3 COPS4 COPS5 COPS6 COPS7A COPS8
GPS1 1 −0.059 0.303 0.369 0.385 0.75 0.522 0.519
COPS2 −0.059 1 0.783 0.676 0.683 0.072 0.587 0.415
COPS3 0.303 0.783 1 0.775 0.841 0.536 0.777 0.465
COPS4 0.369 0.676 0.775 1 0.786 0.369 0.797 0.835
COPS5 0.385 0.683 0.841 0.786 1 0.521 0.843 0.618
p 0.012 6.25E-07 3.30E-12 6.90E-10 - 4.09E-04 2.37E-12 1.32E-05
COPS6 0.75 0.072 0.536 0.369 0.521 1 0.479 0.296
COPS7A 0.522 0.587 0.777 0.797 0.843 0.479 1 0.675
COPS8 0.519 0.415 0.465 0.835 0.618 0.296 0.675 1
Tumor GPS1 COPS2 COPS3 COPS4 COPS5 COPS6 COPS7A COPS8
GPS1 1.000 −0.091 0.055 0.012 0.212 0.360 −0.195 0.218
COPS2 −0.091 1.000 0.126 −0.073 0.218 −0.271 −0.029 −0.066
COPS3 0.055 0.126 1.000 0.043 0.033 0.342 −0.213 0.258
COPS4 0.012 −0.073 0.043 1.000 0.024 −0.023 0.300 0.066
COPS5 0.212 0.218 0.033 0.024 1.000 −0.053 −0.196 0.244
p 0.177 0.165 0.836 0.88 - 0.741 0.213 0.12
COPS6 0.360 −0.271 0.342 −0.023 −0.053 1.000 −0.041 0.205
COPS7A −0.195 −0.029 −0.213 0.300 −0.196 −0.041 1.000 −0.197
COPS8 0.218 −0.066 0.258 0.066 0.244 0.205 −0.197 1.000
Normal and matched HNSCC tissues (sample number = 42) were compared for their correlation coefficient values among the COP9 genes
Fig. 2 Chromosomal mapping of genes with highly synchronized expression with the COPS5 gene. The 500 highest ranked genes based
on |rCOPS5| were pooled, and mapped on to chromosomal locations based on their cytoband information. In the top panel, a cartoon
denotes the chromosome 8 (at 8 in x-axis) where the COPS5 gene is located (8q13). The major grid marks on the x-axis (1–22 and X/Y)
depict location of centromeres dividing p and q arms at the left and the right sides, respectively. X and Y chromosomes are combined,
because all genes analyzed in the figure are mapped in both X and Y
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among the top 100 genes, only seven genes were mapped
at 8q, near the COPS5 chromosomal location (8q13.2). In
contrast, genes with high |rCOPS5| in the tumor tissues
were concentrated near COPS5’s chromosomal region
(Fig. 2, bottom); 56 genes out of the top 100 genes were
bound to 8q.
We sought to assess the chromosomal cis-effect on the
COPS5 gene expression more rigorously. To this end,
based on the method by Subramanian et al. we
determined the enrichment score (ES) based on the rcops5
for the groups of genes that are localized within 1 mega
base pairs (Mbp) from the COPS5, and obtained a p-value
based on the null hypothesis that these ES values were not
different from that calculated for genes outside 1 Mbp
from the COPS5 [22]. We have also determined such ES
values for all the genes in the chromosome 8 to determine
the false discovery rate (FDR, q). The ES value for the
COPS5 with the tumor tissues (ES = 0.65, p = 0.02, q =
0.043) was significantly higher than that with the normal
tissues (ES = 0.39, p = 0.27, q = 0.49). The procedure was
applied for the other COP9 genes, and revealed significant
links to the chromosomal cis-effect in the case of the
tumor tissues (Additional file 2: Table S7). Therefore, we
conclude that the COP9 expression in the tumors is disin-
tegrated because the chromosomal cis-effect becomes a
dominant force to express each subunit gene. Further-
more, these results indicated that analysis of the COP9 ex-
pressions in the normal tissues rather than tumor tissues
is pivotal for understanding the COP9’s role in vivo, and
such an analysis is possible using the RNAseq data in the
normal tissues available from TCGA.
Pathway analysis based on KEGG and GO revealed
association of COPS5 expression with mitochondrial
pathways
Genes that belong to particular cell pathways may be
over-represented in the COPS5 correlation coefficient
table. Identifying such pathways should provide import-
ant clues as to COP9’s roles under the normal physi-
ology. Based on the results above, such functional
association should be elucidated with the data derived
from normal tissues, and the large pool of high quality
gene expression data in the TCGA database prompted
us to investigate this possibility. Genes with the top 1000
|rCOPS5| values in the normal tissues were pooled, and
functional pathways available through GO and KEGG
database were associated to each gene (Additional file 3:
Table S10). The GO and KEGG pathways were then
ranked based on the over-representation, and the 20 most
over-represented pathways are shown in Table 4 (the
Table 4 Association of COPS5 with mitochondrial pathways in normal oral tissues
GO and KEGG pathways Found Expected p μ
1 GO:0003954 ~ NADH dehydrogenase activity 28 4 1.1E-16 0.00184
2 GO:0006120 ~mitochondrial electron transport 28 4 1.1E-16 0.00179
3 GO:0070469 ~ respiratory chain 42 6 1.1E-16 0.00323
4 GO:0042773 ~ ATP synthesis coupled electron transport 34 5 1.1E-16 0.00233
5 GO:0042775 ~mitochondrial ATP synthesis coupled electron transport 34 5 1.1E-16 0.00233
6 GO:0005747 ~mitochondrial respiratory chain complex I 27 4 1.1E-16 0.00179
7 GO:0030964 ~ NADH dehydrogenase complex 27 4 1.1E-16 0.00179
8 GO:0045271 ~ respiratory chain complex I 27 4 1.1E-16 0.00179
9 GO:0045333 ~ cellular respiration 50 8 1.1E-16 0.00437
10 GO:0044455 ~mitochondrial membrane part 62 10 1.1E-16 0.00571
11 hsa00190 ~ oxidative phosphorylation 61 10 1.1E-16 0.00576
12 GO:0005746 ~mitochondrial respiratory chain 36 6 1.1E-16 0.00278
13 GO:0006119 ~ oxidative phosphorylation 48 8 1.1E-16 0.00442
14 GO:0022904 ~ respiratory electron transport chain 35 6 1.1E-16 0.00273
15 GO:0016655 ~ oxidoreductase activity 28 5 1.1E-16 0.00213
16 GO:0022900 ~ electron transport chain 48 9 1.1E-16 0.00516
17 GO:0015980 ~ energy derivation by oxidation of organic compounds 57 11 1.1E-16 0.00670
18 GO:0000313 ~ organellar ribosome 24 5 1.1E-16 0.00238
19 GO:0005761 ~mitochondrial ribosome 24 5 1.1E-16 0.00238
20 GO:0005743 ~mitochondrial inner membrane 96 21 1.1E-16 0.01454
Found: Number of genes in a particular GO or KEGG pathway found in the top 1000 rCOPS5 list; Expected: number of expected genes to yield p < 0.05 appearing in
1000 genes based on the average appearance per gene (μ); μ values were calculated by the total appearance of individual pathways in the entire gene list of
20,154. P values were calculated using binomial distribution in R. Expected occurrences in a list of 1000 genes to provide p < 0.05 are listed
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expanded list is shown in Additional file 4: Table S11).
Unexpectedly, the pathways related to mitochondrial
functions and components were highly over-represented.
For example, 61 genes belonging to the oxidative phos-
phorylation KEGG pathway (hsa00190) were among the
genes with high expression correlation with COPS5 out of
106 total genes (p < 1.1e-16). A number of GO pathways
involving mitochondrial functions were also found
among the over-represented pathways. These included
respiratory chain (GO:0070469), mitochondrial elec-
tron transport (GO:0006120), NADH dehydrogenase
activity (GO:0003954), mitochondrial respiratory chain
complex I (GO:0005747). In fact, all of the 20 most over-
represented pathways are directly related to major mito-
chondrial and energy derivation functions. At the time this
study was carried out, gene ontology database had not yet
linked COPS5 to any of mitochondrial-related pathways.
Expression values were examined in pair-plots for COPS5
and mitochondrial genes of the five highest rCOPS5,
NDUFB6, MRPS36, ATP5F1, TMEM126A, NDUFB3
(Fig. 3). The results illustrate high integrity of the
data and the coordination of the expression of the
COPS5 with the mitochondria related genes.
Dependency on the anatomical sites and smoking history
were tested with the same subgroups as described above
(Additional file 5: Table S12). The mRNA expression data
from the two major anatomical sites, oral cavity and oral
tongue, resulted in almost identical over-representation of
the mitochondrial pathways with COPS5. The same
conclusion was made with the subgroup containing only
the current smokers.
Alteration of COPS5 expression coordination in cancer
tissues
The gene expression coordination between the COPS5
gene and the mitochondrial pathways was elucidated with
tumor tissues (Table 5 and Additional file 4: Table S11).
Although a few GO pathways related to mitochondrial
functions were over-represented, major pathways associ-
ated with the COPS5 expression were those involved in
ribosome processing and RNA binding as well as mem-
brane lumen pathways.
Fig. 3 Pair-wise plot for RNA expression 5 mitochondrial genes. The five genes with the highest rCOPS5 in the normal oral tissues are plotted. 1:
COPS5, 2: NDUFB6, 3: MRPS36, 4: ATP5F1, 5: TMEM126A, 6: NDUFB3
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The possibility that tissues from a particular anatom-
ical site with high dysregulation caused the bias was
addressed. Oral cavity, tongue, and larynx are the major
three sites that together contribute to about 80% of the
donated head and neck cancer tissues. COPS5-associated
GO and KEGG pathways were determined for the tissues
from the particular sites, and confirmed that correlation
of COPS5 expression with mitochondria associated genes
were not as predominant as in the normal tissues.
To further support the finding, enrichment score (ES)
was calculated for the genes in the oxidative phosphoryl-
ation KEGG pathway (hsa00190) using the RNAseq data
of 44 normal head and neck tissues [22] (Fig. 4a). The
obtained ES value, 0.797, was much higher than the
average ES value based on randomly assigned gene pools
(Fig. 4b).
In addition, ES values corresponding to all the other
KEGG pathways were calculated for the 42 matched
normal and tumor tissues (Table 6). The ES value of the
oxidative phosphorylation pathway (hsa00190) found to
be among the highest. The ubiquinone biosynthesis
pathway generated the highest ES value, which is an
essential factor in the respiratory chain and requires
phenylalanine (generating the second highest ES) for its
synthesis. Thus, the enrichment of genes involved in
mitochondria-related pathway based on the COPS5
correlation was exceptionally high.
Table 5 Loss of coordinated expression of COPS5 with mitochondria related genes in the tumor tissues
GO and KEGG Found Expected p μ
1 GO:0015935 ~ small ribosomal subunit 28 6 1.11E-16 3.08E-03
2 GO:0033279 ~ ribosomal subunit 50 11 1.11E-16 6.30E-03
3 GO:0003735 ~ structural constituent of ribosome 58 13 1.11E-16 7.94E-03
4 GO:0005840 ~ ribosome 68 16 1.11E-16 1.02E-02
5 hsa03010 ~ ribosome 30 8 1.11E-16 4.42E-03
6 GO:0042254 ~ ribosome biogenesis 36 10 1.11E-16 6.10E-03
7 GO:0006414 ~ translational elongation 32 9 1.11E-16 5.06E-03
8 GO:0006412 ~ translation 79 23 1.11E-16 1.60E-02
9 GO:0022613 ~ ribonucleoprotein complex biogenesis 47 14 1.11E-16 9.03E-03
10 GO:0030529 ~ ribonucleoprotein complex 112 34 1.11E-16 2.54E-02
11 GO:0044445 ~ cytosolic part 39 12 1.11E-16 7.49E-03
12 GO:0005739 ~mitochondrion 154 65 1.11E-16 5.33E-02
13 GO:0044429 ~mitochondrial part 88 38 1.11E-16 2.90E-02
14 GO:0003723 ~ RNA binding 103 46 1.11E-16 3.61E-02
15 GO:0006396 ~ RNA processing 79 36 1.11E-16 2.75E-02
16 GO:0005730 ~ nucleolus 96 45 1.11E-16 3.47E-02
17 GO:0070013 ~ intracellular organelle lumen 217 104 1.11E-16 8.90E-02
18 GO:0031974 ~membrane-enclosed lumen 223 108 1.11E-16 9.28E-02
19 GO:0043233 ~ organelle lumen 217 106 1.11E-16 9.10E-02
20 GO:0031981 ~ nuclear lumen 176 86 1.11E-16 7.25E-02
The analysis was carried out in the same way as for Table 5
A
B
Fig. 4 Enrichment score for KEGG oxidative phosphorylation
pathway. a The enrichment score was calculated for the oxidative
phosphorylation KEGG pathway (hsa00190). Genes are aligned on x-
axis based on their correlation coefficients to the COPS5 expression.
The hsa00190 pathway contained 106 genes in the entire list. b 106
randomly selected genes were used to calculate ES using the rCOPS5
gene list as in A. The histogram was generated by iteration of 1000
times. The arrow indicates the ES for hsa00190 (0.797, p < 1E-16)
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To elucidate the significance of the COP9 coordin-
ation with oxidative phosphorylation compared to other
genes, we calculated ES values relative to the hsa00190
KEGG pathway for the entire gene list in the RNAseq
data of the matched normal and tumor tissues to calcu-
late FDR (Additional file 2: Table S9). Except for the
COPS7B gene, all the COP9 subunit genes showed
highly significant correlations with the genes in the oxi-
dative phosphorylation pathway. Not surprisingly, most
of the genes in the hsa00190 oxidative phosphorylation
pathway resulted in the high ES/low FDR values, validat-
ing our approach to detect a linkage of a gene to the oxi-
dative phosphorylation. Remarkably, the COP9 genes
(except for COPS7B) were ranked comparably with the
hsa00190 genes. The p as well as FDR values were in-
creased for all the COP9 genes (but COPS7B) with the
tumors, indicating significant decrease in the association
of the COP9 expression to the oxidative phosphorylation
related genes. Taken all together, we conclude that there
is a high synergy between the expression of the COP9
and mitochondria functions, which implies that the nor-
mal physiological function of the COP9 may be insepar-
able from the mitochondrial activity.
Analysis of gene expression of other cancers in the TCGA
database
Finally, the question was addressed whether the associ-
ation of the expressions of COP9 genes with those of
mitochondrial genes was unique in head and neck tissues.
To probe this, the RNA expression data of TCGA for the
lung squamous cell carcinoma tissues were analyzed.
Tumors originating from the lung upper airway epithelia
share similarity with HNSCC in its etiology and its
involvement of smoking as an important risk factor. First,
the synergistic expression pattern of COP9 genes in
the normal tissues (n = 50) was examined, and found
to be highly synergistic with one another (Table 7 and
Additional file 1: Figure S2). Exceptions were GPS1
and COPS7B, which showed lower correlation coeffi-
cients to other COP9 factors. The high positive corre-
lations were again lost in the tumor tissues. These
results showed a remarkable coincidence with those of
head and neck normal and tumor tissues.
The functional pathway analysis with the entire gene list
resulted in the high correlation of the COPS5 expression
with the mitochondrial genes (Additional file 6: Table S13).
Unlike the case of head and neck squamous cell carcinoma,
however, the coordinated expression of COP9 and the
mitochondrial genes was maintained well in the lung squa-
mous cell carcinoma tissues (Additional file 6: Table S13).
Discussion
Cancer genetics and analyses of the TCGA database
mainly focus on the loss of genomic integrity. Mutations
and single nucleotide polymorphism in DNA show the
high rate of permanent alteration of the genome, epigen-
etic modification of the genome, RNA and miRNA
expression alterations. TCGA data sets are available pub-
licly for these types of analyses. The database is highly reli-
able and allowed us to examine cancer genomics with
more than 500 tumor specimens [24].
In addition to the tumor specimens, data from about
40 to 50 normal tissues are made available for most
types of cancers with a notable exception for glioblast-
oma. Although the data sizes are smaller than those for
the cancer tissues, they are arguably one of the most
comprehensive databases for genomics of human speci-
mens of non-disease status with pathological and clinical
scrutiny, which should provide valuable information for
Table 6 Enrichment scores for the COPS5 gene on KEGG pathways
KEGG pathways ES Min Nh p
1 hsa00130 Ubiquinone and other terpenoid-quinone biosynthesis 0.919 −0.004 6 0.001
2 hsa00400 Phenylalanine 0.811 −0.028 3 0.038
3 hsa00190 Oxidative phosphorylation 0.797 0.000 106 0.000
4 hsa00630 Glyoxylate and dicarboxylate metabolism 0.752 −0.014 13 0.001
5 hsa00053 Ascorbate and aldarate metabolism 0.750 −0.083 6 0.001
6 hsa00062 Fatty acid elongation in mitochondria 0.745 −0.027 8 0.004
7 hsa03050 Proteasome 0.734 −0.004 41 0.000
8 hsa00640 Propanoate metabolism 0.698 −0.003 29 0.000
9 hsa00620 Pyruvate metabolism 0.691 −0.006 34 0.000
10 hsa04260 Cardiac muscle contraction 0.676 −0.001 56 0.000
All KEGG pathways found in the entire gene list of the TCGA RNA expression database (199) were individually scanned through the rCOPS5 alignment, and the
maximum (ES) as well as minimum (Phit - Pmiss) were calculated as previously described [1]. The KEGG pathways that generated the 10 highest ES values are
shown. Nh: number of genes belonging to a KEGG pathway in the entire list. A p value for a particular KEGG pathway with an Nh (= Nk) was determined using
mean and standard deviation obtained by the following method. Nk genes were randomly selected from the rCOPS5 list and calculated an ES value, which was
reiterated for 1000 times to generate the mean and standard deviation of ES
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elucidating functions of a gene under the normal physi-
ology. We hypothesized that a synergistic expression of
genes may be observed in the normal tissues, when
expressions of a group of genes need to be coordinated
for their proper cellular activities. COP9 signalosome is
an ideal subject to test this possibility, because all eight
subunits are essential for the proper COP9 function;
deficiency in one of the COP9 genes decreased stability
of the other subunits and caused lethality [23, 25]. In
this study the COP9 signalosome genes showed highly
synergistic expressions in the normal head and neck tis-
sues, except for GPS1 and COPS7B. Remarkably, these
characteristics, including the lower r values for GPS1
and COPS7b, were maintained well even in the lung and
breast normal tissues (data not shown). The coordinated
expression of the COP9 genes decreased in the tumor
tissues. Therefore, this coordination could not have been
detected by analyzing tumor tissues. Likewise, because
all cells cultured in vitro are under non-physiological
conditions and thus transformed at some extent, it
would have been difficult to obtain convincing evidence
for the expression correlation of the COP9 subunit
genes based on in vitro cell biological studies alone.
It is interesting to observe the lowest coordination of
GPS1 expression compared to the other COP9 compo-
nents (excluding COPS7B). Besides being a subunit of
COP9, GPS1 is known for its function in suppression of
G-protein and mitogen-activated signal transduction in
mammalian cells [26]. This COP9-independent function
quite likely requires a regulation of the GPS1 gene separ-
ate from the other COP9 genes.
COPS7B not only had the lowest r value, but also sig-
nificantly lower expression compared to COPS7A
(Additional file 1: Figure S1). While COPS7A and
COPS7B genes are encoded in different human chro-
mosomes, chromosome 12 and 2 respectively, there is a
high homology between COPS7A and COPS7B in the
amino acid sequence (78% identical). Thus, COPS7B
may have only a minor functional role for COP9, which
may be compensated by COPS7A.
To our knowledge, using the exact physical map of the
transcription start sites available from the Ensemble gen-
ome database has not been applied previously to elucidate
effects of the relative locations of genes on the gene
expression correlations. In this study, we used this ap-
proach to find the chromosomal locations of the genes as
Table 7 Synchronized expression of the COP9 genes in the matched tissues of normal and lung squamous cell carcinoma
Correlation Coefficient among COP9 genes, Lung Squamous Cell Carcinoma (n = 50)
Normal GPS1 COPS2 COPS3 COPS4 COPS5 COPS6 COPS7A COPS7B COPS8
GPS1 1.000 −0.092 0.268 0.269 0.278 0.717 0.781 0.194 0.244
COPS2 −0.092 1.000 0.792 0.844 0.742 0.300 0.193 −0.432 0.725
COPS3 0.268 0.792 1.000 0.910 0.859 0.557 0.455 −0.373 0.837
COPS4 0.269 0.844 0.910 1.000 0.909 0.603 0.524 −0.279 0.910
COPS5 0.278 0.742 0.859 0.909 1.000 0.550 0.497 −0.141 0.859
p 0.051 6.85E-10 1.33E-15 0.00E + 00 - 3.49E-05 2.40E-04 0.329 1.55E-15
COPS6 0.717 0.300 0.557 0.603 0.550 1.000 0.716 −0.009 0.602
COPS7A 0.781 0.193 0.455 0.524 0.497 0.716 1.000 0.197 0.461
COPS7B 0.194 −0.432 −0.373 −0.279 −0.141 −0.009 0.197 1.000 −0.257
COPS8 0.244 0.725 0.837 0.910 0.859 0.602 0.461 −0.257 1.000
Tumor GPS1 COPS2 COPS3 COPS4 COPS5 COPS6 COPS7A COPS7B COPS8
GPS1 1.000 0.059 0.261 0.228 0.109 0.529 0.307 0.304 0.193
COPS2 0.059 1.000 0.413 0.488 0.142 0.105 0.143 −0.180 0.207
COPS3 0.261 0.413 1.000 0.240 0.267 0.466 0.320 −0.075 0.137
COPS4 0.228 0.488 0.240 1.000 0.235 0.082 0.023 0.076 0.177
COPS5 0.109 0.142 0.267 0.235 1.000 0.233 0.103 0.212 0.170
p 0.452 0.326 0.061 0.101 - 0.103 0.477 0.139 0.239
COPS6 0.529 0.105 0.466 0.082 0.233 1.000 0.640 0.120 0.180
COPS7A 0.307 0.143 0.320 0.023 0.103 0.640 1.000 −0.094 0.008
COPS7B 0.304 −0.180 −0.075 0.076 0.212 0.120 −0.094 1.000 0.613
COPS8 0.193 0.207 0.137 0.177 0.170 0.180 0.008 0.613 1.000
The analysis was carried out in the same way as for Table 3. Values in bold letters indicate significantly high COSP5 correlation with other COP9 components
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a dominant factor causing the loss of the coordinated
expressions of the COP9 genes. Much fewer number of
genes were under the control of this cis-effect in case of
normal tissues, indicating that most genes in normal tis-
sues are regulated independently of their chromosomal
locations and perhaps more based on their functional
groups, as supported by this study. Therefore, important
implications derived from this analysis are that 1) analyz-
ing tumor tissue data may not identify a normal function
of a protein family such as COP9, and 2) the qualities of
the normal tissue data available in TCGA are high enough
to help identifying unknown expressional linkages with
functional pathways. Although the primary focus of this
study was COP9 expression profiling, we expanded the
analysis of the influence of the chromosomal location for
all the genes that were analyzable in the RNAseq data,
and the data for cancer genes (hsa05200) are shown in
Additional file 7: Table S14. It may be interesting to eluci-
date whether these proto-oncogenes have tight association
with the chromosomal locations in other types of tumor
tissues available in TCGA.
The observation that the expression of the COPS5
gene (and therefore the other COP9 genes) was synchro-
nized with those involved in mitochondrial function was
unexpected. The correlation coefficients of the COPS5
and top ranked genes such as NDUFB6 and MRPS36
(Fig. 3) were remarkably high with statistical signifi-
cance. Moreover, not only a handful of genes involved in
mitochondria but also the total pathway analysis re-
vealed that mitochondria-related cellular functions and
pathways were predominantly over-represented in the
COPS5 correlation coefficient table. Although there have
not been reports that show direct function of COP9 for
mitochondria, correlation analyses with the TP53 of which
functions have been extensively studied linked it with
known cellular functions including cell cycle and DNA
damage response pathways (Additional file 8: Table S15).
The result validates the approach in this study, and
support the prediction that the COP9 signalosome has a
novel functional link to mitochondrial activities.
Few studies have linked COP9 to mitochondria-related
cellular activities. Jab1/COPS5 was previously identified as
an apoptosis inducing factor through modulation of mito-
chondrial BH3-domain containing protein BclGs [27]. A
study found that in Neurospora crassa, three subunits of the
COP9 were required to recover from deficiency of the alter-
native oxidase function, which is important for mitochon-
drial functions [28]. However, no follow up studies have
been carried out for mammalian cells. On the other hand,
pathways involved in ribosomal functions were associated
with the COPS5 expression in the tumor tissues. The signifi-
cance of this link is currently unclear. However, the COP9
structure is homologous to translation initiation factor 3
(eIF3), another high-ordered complex in the cells [29], and
our speculation is that COPS5 may have an overlapping
function in the protein synthesis in transformed cells.
The quantity and quality of the genomics database
will only be improved. The present study underscores
the importance and usefulness of examining the gen-
omics of normal tissues. The results would provide
novel functional links of a gene, which was not possible
by analyzing the data set of pathophysiological speci-
mens. This approach can reasonably be applied to other
genes to identify pathways that have not been known
due to scarce information for genomics information of
normal tissues.
Conclusions
The present study investigated COPS5 gene expression
using the TCGA database. The analysis revealed the
highly synergistic mRNA expression pattern among
COP9 genes in normal oral tissues. The coordination
was abrogated in the tumor tissues, and the regulatory
mechanism was taken over by a cis-acting gene regula-
tion. Further analysis revealed an unexpected expression
correlation between the COPS5 gene and a number of
mitochondria-related genes, postulating the possible
functional role of the COP9 signalosome for mitochon-
drial activities. The quality of the RNA expression data
available in TCGA is high enough to allow us gene
expression analysis in normal tissues to identify gene
functions under normal physiology, which may not be
recognized by the data obtained from tumor tissues.
Additional files
(Additional files Figures and Tables) for Analysis of
RNA expression of normal and cancer tissues reveal
high correlation of COP9 gene expression with respira-
tory chain complex components by Christina A. Wicker
and Tadahide Izumi.
Additional file 1: Figure S1. Expressions of COP9 genes in normal oral
tissues. The RNA expression levels (y-axis) of COP9 genes from 44 normal
oral tissues are shown. Horizontal lines in the boxes: median values. Top
and bottom whiskers denote the first and the third quartile (Q1 and Q3).
Outliers (> Q3 + 1.5 * (Q3 - Q1) and < Q1 - 1.5 * (Q3 - Q1)) are shown as
individual dots. Figure S2. Pair-wise plot for expressions of COP9 genes
in the matched lung tissues of normal and squamous cell carcinoma. The
plots were generated as described in Fig. 1, except for the data set of the
normal (A) and their matched lung squamous cell carcinoma (B) from
TCGA was used. The number of samples = 50. (PDF 1508 kb)
Additional file 2: Table S1. The let-7 expression profilesof the
matched head and neck normal and tumor tissues. Correlation
coefficients for individual let-7 isoforms relative to COP9 genes are
shown. Asterisks: p < 0.05. Table S2. To support the result of Table
3, 2 additional normal head and neck tissues were included to
calculate correlation of expressions among the COP9 genes.
Correlation coefficients of COP9 genes versus COPS5 (rCOPS5) were
determined from randomly selected 44 tumor specimens from the
entire pool of 511. The calculations were repeated for 10,000 times
to obtain their mean and standard deviation (sd) values, which were
used to compare the difference from rCOPS5 of normal tissues.
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Table S3. RNAseq data from young (30 specimens) and elderly
patients (31 specimens) were used to calculate the correlation
coefficients among the COP9 genes. Table S4. 14 normal oral cavity
tissues were pooled based on the TCGA clinical data, and the
correlation coefficients and their p values for COPS5 were calculated
as described in the main article. Table S5. Data based on the 13
normal tongue tissues were pooled based on the clinical data in the
TCGA database, and the correlation coefficients and their p values for
COPS5 were calculated. Table S6. 11 normal tissues from smokers
were pooled based on the clinical data in the TCGA database, and
the correlation coefficients and their p values for COPS5 were
calculated. Table S7. Nh: number of genes found within 1 Mbp of
each COP9 gene; mean, sd, p and q values were determined as
described in Materials and Methods. Table S8. ES for COP9 genes for
all KEGG pathways. Table S9. ES for COP9 genes for the oxidative
phosphorylation pathway. (XLS 80 kb)
Additional file 3: Table S10. The COPS5 correlation coefficient table
list includes 1000 highest |r| values relative to the expression of COPS5
in the normal and tumor tissues of head and neck. (XLSX 621 kb)
Additional file 4: Table S11. GO and KEGG pathways that are over-
represented in the normal and tumor oral tissues based on the COPS5
correlation coefficient table. (XLSX 147 kb)
Additional file 5: Table S12. GO and KEGG pathways over-represented
by COPS5 expression correlation in the two major anatomical sites in the
head and neck (oral cavity and tongue). (XLSX 57 kb)
Additional file 6: Table S13. GO and KEGG pathways over-represented
in the normal and tumor lung tissues based on the COPS5 correlation
coefficient table. (XLSX 44 kb)
Additional file 7: Table S14. Genes under the chromosomal cis-effect
in the HNSCC tissues (XLS 2117 kb)
Additional file 8: Table S15. KEGG pathway analysis for the TP53
gene (XLS 70 kb)
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